Tidal Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$271K Sell
15,525
-2,061
-12% -$40.9K ﹤0.01% 2079
2025
Q4
$345K Buy
17,586
+1,548
+10% +$32.1K ﹤0.01% 1813
2025
Q3
$442K Sell
16,038
-868
-5% -$26.7K ﹤0.01% 1632
2025
Q2
$516K Buy
16,906
+5,318
+46% +$151K ﹤0.01% 1382
2025
Q1
$313K Sell
11,588
-950
-8% -$30.1K ﹤0.01% 1531
2024
Q4
$450K Sell
12,538
-624
-5% -$23.3K ﹤0.01% 1434
2024
Q3
$499K Hold
13,162
0.01% 1387
2024
Q2
$595K Buy
+13,162
New +$606K 0.01% 1211

Other funds holding USNA

Tidal Investments's USNA Position: Q1 2026 in Review

Tidal Investments reduced its Usana Health Sciences (USNA) stake by 12% in Q1 2026, selling an estimated $40.9K and leaving 15,525 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Tidal Investments first reported a position in USNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $595K in Q2 2024. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Tidal Investments held 15,525 shares of Usana Health Sciences worth $271K as of Q1 2026.
  • Tidal Investments sold 2,061 Usana Health Sciences shares in Q1 2026, an estimated $40.9K.
  • Usana Health Sciences made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #2079 holding.
  • Tidal Investments first reported a position in Usana Health Sciences in Q2 2024 and has held it in 8 quarters since.
  • Tidal Investments's Usana Health Sciences position peaked at $595K in Q2 2024.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.